Motorica India conducted a specialised masterclass led by Shumaev, centred on real-life rehabilitation scenarios and personalised therapy programs before and after prosthetic fitting
The company has commissioned a new plant at Khanna (Punjab), which has begun commercial production
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology
The board highlighted ongoing investments in Radiopharma, CDMO Sterile Injectables, and CRDMO businesses
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
Pfizer’s anti-infectives portfolio includes both established therapies for moderate to severe infections and newer, clinically robust antimicrobial treatments
Call it one of the most striking turnarounds in the Indian pharma sector this fiscal year
The PRIOH-1 study met its primary endpoint, delivering statistically significant and clinically meaningful improvements in lesion healing
Subscribe To Our Newsletter & Stay Updated